Integrating the melanoma 31-gene expression profile test with clinical and pathologic features can provide personalized precision estimates for sentinel lymph node positivity: an independent performance cohort-Reference-Cited by-同舟云学术

Integrating the melanoma 31-gene expression profile test with clinical and pathologic features can provide personalized precision estimates for sentinel lymph node positivity: an independent performance cohort

Published:2024-08-30 Issue:1 Volume:22 Page:
ISSN:1477-7819
Container-title:World Journal of Surgical Oncology
language:en
Short-container-title:World J Surg Onc

Author:

Kriza Chase,Martin Brian,Bailey Christine N.,Bennett Joseph

Funder

Castle Biosciences

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12957-024-03512-4.pdf

Reference20 articles.

1. Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370(7):599–609.

2. Multicenter Selective Lymphadenectomy Trials Study Group, Crystal JS, Thompson JF et al. Therapeutic value of sentinel lymph node biopsy in patients with melanoma: a randomized clinical trial. JAMA Surg. 2022 [cited 2022 Aug 9]. https://jamanetwork.com/journals/jamasurgery/fullarticle/2794852

3. Chen J, Xu Y, Zhou Y, Wang Y, Zhu H, Shi Y. Prognostic role of sentinel lymph node biopsy for patients with cutaneous melanoma: a retrospective study of surveillance, epidemiology, and end-result population-based data. Oncotarget. 2016;7(29):45671–7.

4. Aiken TJ, Stahl CC, Schwartz PB, et al. Sentinel lymph node biopsy is associated with increased cost in higher risk thin melanoma. J Surg Oncol. 2021;123(1):104–9.

5. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Cutaneous melanoma 2024. 2024 [cited 2024 May 7]. https://www.nccn.org/professionals/physician_gls/pdf/cutaneous_melanoma.pdf